Compounds > arsenic
Page last updated: 2024-08-26

arsenic and Tachycardia, Ventricular

arsenic has been researched along with Tachycardia, Ventricular in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ducas, J; Ducas, RA; Seftel, MD; Seifer, C1
Fujisawa, S; Fujita, Y; Matsui, H; Naito, K; Nakamura, S; Ohnishi, K; Ohno, R; Satoh, H; Shigeno, K; Shinjo, K; Sugiyama, S; Takeshita, A; Terada, H; Yoshida, H1
Barbey, JT; Soignet, S1

Other Studies

3 other study(ies) available for arsenic and Tachycardia, Ventricular

ArticleYear
Monomorphic ventricular tachycardia caused by arsenic trioxide therapy for acute promyelocytic leukaemia.
    The journal of the Royal College of Physicians of Edinburgh, 2011, Volume: 41, Issue:2

    Topics: Adult; Anti-Arrhythmia Agents; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Electrocardiography; Female; Humans; Leukemia, Promyelocytic, Acute; Magnesium; Manitoba; Metoprolol; Oxides; Potassium; Tachycardia, Ventricular

2011
Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia.
    Annals of internal medicine, 2000, Dec-05, Volume: 133, Issue:11

    Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Electrocardiography, Ambulatory; Female; Humans; Leukemia, Promyelocytic, Acute; Long QT Syndrome; Male; Middle Aged; Oxides; Prospective Studies; Recurrence; Remission Induction; Tachycardia, Ventricular

2000
Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia.
    Annals of internal medicine, 2001, Nov-06, Volume: 135, Issue:9

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Electrocardiography; Humans; Leukemia, Promyelocytic, Acute; Oxides; Tachycardia, Ventricular

2001